SINGULUS TECHNOLOGIES - The MEDLINE Production System for Processing Contact
Lenses Continues to Establish itself on the Market

EQS-News: SINGULUS TECHNOLOGIES AG / Key word(s): Disposal
SINGULUS TECHNOLOGIES - The MEDLINE Production System for Processing Contact
Lenses Continues to Establish itself on the Market

14.05.2024 / 08:00 CET/CEST
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Press Release

SINGULUS TECHNOLOGIES - The MEDLINE Production System for Processing Contact
Lenses Continues to Establish itself on the Market

* Range of applications expanded

* Capacity of the new machine generation significantly higher

Kahl am Main, May 14, 2024 - The MEDLINE production system from SINGULUS
TECHNOLOGIES, which was specially developed for the processing of contact
lenses, is steadily gaining acceptance in the market. In close cooperation
with customers, SINGULUS TECHNOLOGIES has validated the machine technology
required for the processing and production of contact lenses in recent
months. The existing system concepts have been optimized and
customer-specific process and procedure variants have been developed. The
systems are developed and manufactured in compliance with all regulatory
requirements in order to ensure the highest product quality, to fulfill the
regulations of the international health authorities and, in particular, to
comply with the relevant standards and specifications of the GMP and GxP/FDA
regulations for the industry.

Dr.-Ing. Stefan Rinck, CEO of SINGULUS TECHNOLOGIES, emphasizes the
importance of cooperation with key customers: "Our processing systems were
specially developed to clean contact lenses of material residues and then
coat them. We have now developed systems in which different types of contact
lenses, such as daily and monthly disposable lenses, can be reliably
processed." Dr. Rinck adds: "In recent weeks, we have received another order
for such a production system. This shows that we are meeting the
requirements of the market and our customers with our systems."

Background:

SINGULUS TECHNOLOGIES develops wet-chemical processes such as cleaning,
etching and deposition for optical substrates made of glass, polymer or
monomer components and offers customized machines for surface treatment. The
market for contact lenses is a growing sector in the medical technology
industry, characterized by increasing consumer demand for contact lenses and
their diverse medical applications. With the steady market growth and the
innovation dynamics in the area of new products, SINGULUS TECHNOLOGIES sees
promising opportunities to continue to play a leading role in this market in
the future.

Thin-Film Coating and Surface Treatment

SINGULUS TECHNOLOGIES develops and assembles innovative machines and systems
for efficient thin-film coating and surface treatment processes, which are
used worldwide in the Photovoltaics, Semiconductor, Medical Technology,
Packaging, Glass & Automotive as well as Battery & Hydrogen markets.

The company's core competencies include various processes of coating
technology (PVD sputtering, PECVD, evaporation), surface treatment as well
as wet-chemical and thermal production processes. SINGULUS TECHNOLOGIES sees
sustainability as an opportunity to position itself with innovative
products. In the focus are environmental awareness, efficient use of
resources and avoidance of unnecessary CO pollution.

SINGULUS TECHNOLOGIES attaches great importance to responsible and
sustainable corporate governance.

SINGULUS TECHNOLOGIES AG, Hanauer Landstraße 103,
D-63796 Kahl/Main, WKN A1681X / ISIN DE000A1681X5

Contact: Bernhard Krause, Corporate Communications, Tel.: +49 (0) 172 833
2224

Maren Schuster, Investor Relations, Tel.: + 49 (0) 160 9609 0279


---------------------------------------------------------------------------

14.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS
News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        SINGULUS TECHNOLOGIES AG
                   Hanauer Landstrasse 103
                   63796 Kahl am Main
                   Germany
   Phone:          +49 (0)1709202924
   Fax:            +49 (0)6188 440-110
   E-mail:         bernhard.krause@singulus.de
   Internet:       www.singulus.de
   ISIN:           DE000A1681X5, DE000A2AA5H5
   WKN:            A1681X, A2AA5H
   Listed:         Regulated Market in Frankfurt (Prime Standard);
                   Regulated Unofficial Market in Berlin, Dusseldorf,
                   Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
   EQS News ID:    1901929

End of News EQS News Service
---------------------------------------------------------------------------

1901929 14.05.2024 CET/CEST